Hematopoetic Stem Cell Transplantation in Neutrophil Disorders: Severe Congenital Neutropenia, Leukocyte Adhesion Deficiency and Chronic Granulomatous Disease
被引:14
作者:
Elhasid, Ronit
论文数: 0引用数: 0
h-index: 0
机构:
Technion Israel Inst Technol, Rappaport Sch Med, Div Hematol, IL-31096 Haifa, IsraelTechnion Israel Inst Technol, Rappaport Sch Med, Div Hematol, IL-31096 Haifa, Israel
Elhasid, Ronit
[1
]
Rowe, Jacob M.
论文数: 0引用数: 0
h-index: 0
机构:
Technion Israel Inst Technol, Rappaport Sch Med, Div Hematol, IL-31096 Haifa, IsraelTechnion Israel Inst Technol, Rappaport Sch Med, Div Hematol, IL-31096 Haifa, Israel
Rowe, Jacob M.
[1
]
机构:
[1] Technion Israel Inst Technol, Rappaport Sch Med, Div Hematol, IL-31096 Haifa, Israel
Until further progress will occur in the field of gene therapy, the only curative treatment available in severe congenital neutropenia, leukocyte adhesion deficiency, and chronic granulomatous disease is allogeneic hematopoietic stem cell transplantation (HSCT). This review summarizes the current data regarding indications for transplantation in each disease, treatment results using related and unrelated donors, as well as toxicity of HSCT in the above diseases.